Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes

[1] Guo R(2015)DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy J Hum Genet 60 435-442

[2] Zhu G(2019)Core transcription factors promote induction of PAX3-positive skeletal muscle stem cells Stem Cell Rep 13 352-365

[3] Zhu H(2010)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management Lancet Neurol 27 4-14

[4] Ma R(2017)Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: a systematic review Neuromuscul Disord 24 482-491

[5] Peng Y(2014)A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy Neuromuscul Disord 27 715-722

[6] Liang D(2017)Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China Neuromuscul Disord 131 370-389

[7] Sato T(2020)Common therapeutic advances for Duchenne muscular dystrophy (DMD) Int J Neurosci 287 18153-18162

[8] Higashioka K(2012)Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy J Biol Chem 54 227-229

[9] Sakurai H(2013)Cardiac resynchronization therapy in Becker muscular dystrophy Hellenic J Cardiol 37 239-244

[10] Yamamoto T(2016)A novel mutation in DMD (c.1079715G.A) causes Becker muscular dystrophy associated with intellectual disability J Dev Behav Pediatr 28 308-312

[1] Guo R(2015)DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy J Hum Genet 60 435-442

[2] Zhu G(2019)Core transcription factors promote induction of PAX3-positive skeletal muscle stem cells Stem Cell Rep 13 352-365

[3] Zhu H(2010)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management Lancet Neurol 27 4-14

[4] Ma R(2017)Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: a systematic review Neuromuscul Disord 24 482-491

[5] Peng Y(2014)A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy Neuromuscul Disord 27 715-722

[6] Liang D(2017)Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China Neuromuscul Disord 131 370-389

[7] Sato T(2020)Common therapeutic advances for Duchenne muscular dystrophy (DMD) Int J Neurosci 287 18153-18162

[8] Higashioka K(2012)Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy J Biol Chem 54 227-229

[9] Sakurai H(2013)Cardiac resynchronization therapy in Becker muscular dystrophy Hellenic J Cardiol 37 239-244

[10] Yamamoto T(2016)A novel mutation in DMD (c.1079715G.A) causes Becker muscular dystrophy associated with intellectual disability J Dev Behav Pediatr 28 308-312